NRAGE promotes the malignant phenotype of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a fatal disease, primarily due to the limited effective therapies available for patients with advanced or recurrent stages of the disease. Therefore, in order to improve patient prognosis, it is important to identify an informative biomarker for HCC progression, as...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: SHIMIZU, DAI, KANDA, MITSURO, SUGIMOTO, HIROYUKI, SUEOKA, SATOSHI, TAKAMI, HIDEKI, EZAKA, KAZUHIRO, TANAKA, YURI, HASHIMOTO, RYOJI, OKAMURA, YUKIYASU, IWATA, NAOKI, TANAKA, CHIE, YAMADA, SUGURU, FUJII, TSUTOMU, NAKAYAMA, GORO, KOIKE, MASAHIKO, NOMOTO, SHUJI, FUJIWARA, MICHITAKA, KODERA, YASUHIRO
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2016
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4774420/
https://ncbi.nlm.nih.gov/pubmed/26998088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.4120
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados